ČESKÁ UROLOGIE / CZECH UROLOGY – 1 / 2020

49 ORIGINÁLNÍ PRÁCE Ces Urol 2020; 24(1): 42–50 V našem souboru nebyla celková prognóza pacienta ovlivněna nálezem IKP. Seznam použitých zkratek: ◼ IKP – incidentální karcinom prostaty ◼ KP – karcinom prostaty ◼ KM – karcinom močového měchýře ◼ RCP – radikální cystoprostatektomie ◼ WMS – Whole‑Mount Section (celoplošné řezy) ◼ PSA – prostatický specifický antigen ◼ SVI – Seminal Vesical Invasion ◼ EPE – Extra Prostatic Extension ◼ PZ – periferní zóna ◼ TZ – přechodová zóna ◼ CZ – centrální zóna ◼ iPSA – iniciální PSA LITERATURA: 1. Holund, B. Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol 1980. 14(1): p. 29–35. 2. Autorino RG, Di Lorenzo R, Damiano G, et al. Pathology of the prostate in radical cystectomy speci‑ mens: a critical review. Surg Oncol 2009; 18(1): 73–84. 3. Davila HHT, Weber D, Burday S, et al. Total or partial prostate sparing cystectomy for invasive bladder cancer: long‑term implications on erectile function. BJU Int 2007; 100(5): 1026–1029. 4. Jhavar SGC, Fisher A, Jackson SA, et al. Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique. Journal of clinical pathology 2005; 58(5): 504–508. 5. Samaratunga HR, Montironi L, True JI, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol 2011; 24(1): 6–15. 6. Freedland SJME, Sutter F, Dorey, Aronson WJ. Defining the ideal cutpoint for determining PSA recu‑ rrence after radical prostatectomy. Prostate‑specific antigen. Urology 2003; 61(2): 365–369. 7. Buse ST, Hofner SC, Muller E, et al. Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy. Int J Urol 2013; 20(9): 866–871. 8. Pignot GL, Salomon Y, Neuzillet A, et al. Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study. Ann Surg Oncol 2014; 21(2): 684–690. 9. Barbisan FR, Mazzucchelli M, Scarpelli A, et al. Urothelial and incidental prostate carcinoma in prosta‑ tes from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? BJU Int 2009; 103(8): 1058–1063. 10. Yin MS, Bastacky U, Chandran MJ, Becich, Dhir R. Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors. J Urol 2008; 179(3): 892–895; discussion 895. 11. Mazzucchelli RF, Barbisan M, Scarpelli A, et al. Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant? Am J Clin Pathol 2009; 131(2): 279–283. 12. Prošvic PP, Morávek, Šimáková E. Incidentální adenokarcinom prostaty u pacientů po radikální cys‑ tektomii pro uroteliální karcinom. Ces Urol 2002; 6(1): 37–40. 13. Kudláčková Š, Král M, Grepl M, Študent V. Výskyt karcinomu prostaty u mužů v materiálu po RACE. Ces Urol 2015; 19(Suppl. B): 33–33. 14. Zhu YP, DW Ye XD, Yao SL, et al. Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries. Asian J Androl 2009; 11(1): 104–108. 15. Androulakakis PAHM, Schneider GH, Jacobi, Hohenfellner R. Coincident vesical transitional cell carcinoma and prostatic carcinoma. Clinical features and treatment. Br J Urol 1986; 58(2): 153–156.